Atlas Trials

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Clinical trial NCT01207492 · COMPLETED

Trial details

NCT number
NCT01207492
Sponsor
Andrew J. Wagner, MD, PhD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pigmented Villonodular SynovitisDiffuse-type Giant Cell TumorTenosynovial Giant Cell Tumor
Start date
2010-09-01
Primary completion
2014-04-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.